WC
ELV icon

Weil Company’s Elevance Health ELV Stock Holding History

Weil Company’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-472
Closed -$205K – 115
2025
Q1 		$205K Buy
+472
New +$189K 0.06% 103
2024
Q4 		– Sell
-442
Closed -$230K – 117
2024
Q3 		$230K Hold
442
– – 0.08% 137
2024
Q2 		$240K Sell
442
-172
-28% -$90.9K 0.09% 136
2024
Q1 		$318K Buy
614
+34
+6% +$16.9K 0.13% 119
2023
Q4 		$274K Hold
580
– – 0.12% 118
2023
Q3 		$253K Hold
580
– – 0.13% 116
2023
Q2 		$258K Hold
580
– – 0.11% 122
2023
Q1 		$267K Buy
+580
New +$276K 0.12% 116
2019
Q4 		– Sell
-30
Closed -$7K – 179
2019
Q3 		$7K Buy
+30
New +$8.22K 0.01% 311

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Weil Company's ELV Position: Q2 2025 in Review

Weil Company sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 472 shares — an estimated $205K sold.

Weil Company first reported a position in ELV in Q3 2019 and held it in 9 quarters. The position peaked at $318K in Q1 2024. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Weil Company reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Weil Company sold 472 Elevance Health shares in Q2 2025, an estimated $205K.
  • Weil Company first reported a position in Elevance Health in Q3 2019 and held it in 9 quarters.
  • Weil Company's Elevance Health position peaked at $318K in Q1 2024.
  • 1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Weil Company's 13F filing for Q2 2025, filed 7 Aug 2025.